Table 4 Antibiotic resistance and ESBL production in HvKp and cKp Isolates.
Antimicrobial agent | hvKp (n = 18) (%) | cKp (n = 169) (%) | p-value |
|---|---|---|---|
ESBL production | 1.9 | 1.84 | 0.36 |
Amikacin 30 µg | 55.5 | 65 | 0.456 |
Gentamycin 10 µg | 61.1 | 60 | 0.914 |
Cefepime 30 µg | 66.6 | 75.1 | 0.437 |
Ceftazidime 30 µg | 72.2 | 76.6 | 0.701 |
Ciprofloxacin 5 µg | 72.2 | 75.2 | 0.789 |
Trimethoprim/Sulfamethoxazol 1.25/23.75 µg | 72.2 | 71.2 | 0.958 |
Imipenem 10 µg | 61.1 | 66.6 | 0.702 |
Cefotaxime 30 µg | 72.2 | 76.7 | 0.701 |
Cefazolin 30 µg | 66.6 | 78.9 | 0.247 |
